AHA letter to the US Senate supporting Amendment #3787 to address âout-of-control costâ of prescription drugs.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
RE: CMS-1720-NC, Request for Information Regarding the Physician Self-referral Law
AHA shares Value-Based Care recommendations with Congressional Caucus.
AHA comments on the Centers for Medicare & Medicaid Services' agency information collection notice on the home health âReview Choiceâ demonstration.
AHA letter to the Senate expressing support for Robert Wilkie Department.of Veteran Affairs Nomination.
AHA expresses disappointment that the Agency for Healthcare Research and Quality is shutting down the National Guidelines Clearinghouse.
AHA, health organizations letter to CMS regarding its decision to suspend billions of dollars in annual payments to insurers as required under the Affordable Care Actâs risk-adjustment program.
AHA comments on the 340B section of the Department of Health and Human Servicesâ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
AHA comments on the Department of Health and Human Servicesâ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs.Â